ET
TXG icon

Entropy Technologies’s 10x Genomics TXG Stock Holding History

Entropy Technologies’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-30,617
Closed -$355K – 1098
2025
Q2 		$355K Buy
+30,617
New +$279K 0.03% 569
2025
Q1 		– Sell
-37,595
Closed -$540K – 989
2024
Q4 		$540K Buy
37,595
+27,844
+286% +$439K 0.06% 418
2024
Q3 		$220K Sell
9,751
-12,974
-57% -$268K 0.02% 618
2024
Q2 		$442K Sell
22,725
-3,747
-14% -$98.1K 0.05% 422
2024
Q1 		$993K Buy
+26,472
New +$1.16M 0.11% 287

Other funds holding TXG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Entropy Technologies's TXG Position: Q3 2025 in Review

Entropy Technologies sold out of 10x Genomics (TXG) in Q3 2025, closing a stake of 30,617 shares — an estimated $355K sold.

Entropy Technologies first reported a position in TXG in Q1 2024 and held it in 5 quarters. The position peaked at $993K in Q1 2024. 317 funds tracked by Wall St. Rank hold TXG as of Q3 2025.

  • Entropy Technologies reported no remaining 10x Genomics position as of Q3 2025 after selling out during the quarter.
  • Entropy Technologies sold 30,617 10x Genomics shares in Q3 2025, an estimated $355K.
  • Entropy Technologies first reported a position in 10x Genomics in Q1 2024 and held it in 5 quarters.
  • Entropy Technologies's 10x Genomics position peaked at $993K in Q1 2024.
  • 317 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2025.

Based on Entropy Technologies's 13F filing for Q3 2025, filed 13 Nov 2025.